Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Arcadia Biosciences (RKDA) Assets Average (2016 - 2025)

Historic Assets Average for Arcadia Biosciences (RKDA) over the last 11 years, with Q3 2025 value amounting to $8.2 million.

  • Arcadia Biosciences' Assets Average fell 4979.45% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 million, marking a year-over-year decrease of 4979.45%. This contributed to the annual value of $16.6 million for FY2024, which is 3167.99% down from last year.
  • Latest data reveals that Arcadia Biosciences reported Assets Average of $8.2 million as of Q3 2025, which was down 4979.45% from $10.4 million recorded in Q2 2025.
  • In the past 5 years, Arcadia Biosciences' Assets Average ranged from a high of $70.8 million in Q2 2021 and a low of $8.2 million during Q3 2025
  • Over the past 5 years, Arcadia Biosciences' median Assets Average value was $28.6 million (recorded in 2023), while the average stood at $31.2 million.
  • As far as peak fluctuations go, Arcadia Biosciences' Assets Average soared by 10220.78% in 2021, and later tumbled by 4979.45% in 2025.
  • Quarter analysis of 5 years shows Arcadia Biosciences' Assets Average stood at $51.6 million in 2021, then crashed by 38.54% to $31.7 million in 2022, then tumbled by 31.9% to $21.6 million in 2023, then tumbled by 33.39% to $14.4 million in 2024, then crashed by 43.07% to $8.2 million in 2025.
  • Its Assets Average was $8.2 million in Q3 2025, compared to $10.4 million in Q2 2025 and $13.3 million in Q1 2025.